Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-11

FDA Approved: OXALIPLATIN — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Meitheal Pharmaceuticals' original application for a generic oxaliplatin product used to treat colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

ORIG AP for OXALIPLATIN (OXALIPLATIN)